Characterization of Interferon Beta -1b-Induced Tolerizing Effect in Dendritic Cells

You may be eligible if

• Confirmed diagnosis of MS
• Age 18-60 years, inclusive
• Expanded disability status of 0-6.5
• Give written informed consent prior to any testing under this protocol